ACE2 and infection: Prior or ongoing infections of mucosal, epithelial, and endothelial cells—associated with inflammation in the respiratory, renal, vascular, gastrointestinal, or cardiac tissues—raise the expression of ACE2, making these tissues more vulnerable to SARS-CoV-2 infection [208].